Abstract
Preimplantation genetic diagnosis (PGD) is used in an effort to decrease spontaneous abortion, prevent the birth of aneuploid offspring and to potentially increase implantation by removing genetically abnormal embryos from the pool of embryos to be transferred. All currently available information regarding rates of aneuploidy among human preimplantation embryos comes from PGD of embryos of people with impaired fertility. In this population, aneuploidy screening is suggested for women with recurrent pregnancy loss, the transfer of good quality embryos without achieving a viable pregnancy or women of advanced maternal age.
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
